ADHD Explosion—New Drugs are Here!
1.25 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non- members, this continuing education activity rate is $25.
This presentation will review current, state of the art treatments for ADHD including the eight new drugs approved since 2015. We will also discuss treating ADHD in the presence of neurologic comorbidities such as tics, anxiety and autism when access to pediatric psychiatrists and behavioral health specialists is becoming more difficult in the era of COVID.
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program will be awarded 1.25 NAPNAP contact hour, of which 0.75 is pharmacology and 0.75 is psychopharmacology content.
IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: firstname.lastname@example.org
Copyright 2022 © by National Association of Pediatric Nurse Practitioners (NAPNAP).
Pediatric-focused advanced practice registered nurses
• Describe difference in pharmacokinetics of stimulant versus non-stimulant medications.
• Review the key indications and strategies for using newer medications in the treatment of ADHD.
• Identify preferred medications when treating ADHD in the presence of neurologic comorbidities.
Erin O'Connor Prange, MSN, CRNP
Erin O’Connor Prange is a PNP from The Children’s Hospital of Philadelphia. She received her MSN from the University of Pennsylvania and has worked as a neurology NP at CHOP for more than 18 years. During this time, she has provided outpatient care for general neurology patients as well as participated in several multi-disciplinary clinics including the pediatric multiple sclerosis program, Leukodystrophy Center of Excellence, Rett Center of Excellence and CDKL5 Center of Excellence. In addition to outpatient care, she enjoys teaching and mentoring the inpatient APPs, precepting nurse practitioner students and engaging in research. Most recently she helped lead a quality improvement study “Can Clinicians Differentiate Rett Spells from Epileptic Seizures without LTM EEG?”
- 1.25 Contact hours